AOP ORPHAN FOCUS ON RARE DISEASES

Serial Number 79192641
Registration 5225397
709

Registration Progress

Application Filed
Jun 2, 2016
Under Examination
Approved for Publication
Apr 4, 2017
Published for Opposition
Apr 4, 2017
Registered
Jun 20, 2017

Trademark Image

AOP ORPHAN FOCUS ON RARE DISEASES

Basic Information

Serial Number
79192641
Registration Number
5225397
Filing Date
June 2, 2016
Registration Date
June 20, 2017
Published for Opposition
April 4, 2017
Cancellation Date
January 5, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
709
Status Date
Jan 5, 2024

Rights Holder

AOP Orphan Pharmaceuticals GmbH

03
Address
Leopold-Ungar-Platz 2
A-1190 Wien
AT

Ownership History

AOP Orphan Pharmaceuticals AG

Original Applicant
03
AT

AOP Orphan Pharmaceuticals AG

Owner at Publication
03
AT

AOP Orphan Pharmaceuticals GmbH

Original Registrant
03
AT

Legal Representation

Attorney
Michael Fedrick

Application History

33 events
Date Code Type Description Documents
Sep 29, 2024 INNT P TOTAL INVALIDATION PROCESSED BY THE IB Loading...
Sep 11, 2024 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Loading...
Sep 11, 2024 INPC P INVALIDATION PROCESSED Loading...
Sep 6, 2024 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Jan 5, 2024 C71T O CANCELLED SECTION 71 Loading...
Jun 20, 2022 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Dec 18, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Nov 26, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Oct 28, 2017 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 22, 2017 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 22, 2017 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 20, 2017 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 20, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 4, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 4, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 1, 2017 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Mar 15, 2017 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 15, 2017 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Mar 15, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 28, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 28, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 27, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 27, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 25, 2016 RFNT P REFUSAL PROCESSED BY IB Loading...
Nov 4, 2016 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 4, 2016 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Oct 16, 2016 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Oct 15, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 15, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 11, 2016 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 5, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 5, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 1, 2016 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Design Mark
The mark consists of the wording "AOP ORPHAN FOCUS ON RARE DISEASES" in gray. To the left of the wording appears a design of two ellipses and two circles in red forming an arc and decreasing in size, with the largest ellipse laying flat, the next ellipse partially raised from the flat ellipse, and the two smaller circles appearing to be floating in the air.
Color Claim
The color(s) gray and red is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ORPHAN" AND "FOCUS ON RARE DISEASES"